Radiation therapy for pancreatic cancer before surgery
Part of Cancer clinical trials.
This trial tests a special type of radiation therapy for people with pancreatic cancer who are going to have chemotherapy and then surgery. The radiation is 'painted' to give more dose to the tumor and less to nearby healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a type of pancreatic cancer called pancreatic ductal adenocarcinoma (PDAC) that has not spread to other organs
- Your doctor has recommended you have chemotherapy and radiation before surgery
- You have not had radiation to your chest, belly, or pelvic area before
- You have not had another cancer (except certain skin cancers) in the last 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving targeted radiation (SBRT) followed by an experimental immunotherapy drug injected directly into the tumor is safe for people with locally advanced pancreatic cancer. It aims to shrink the tumor and help your immune system fight it.
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
This trial tests a combination of four drugs (liposomal irinotecan, 5-fluorouracil, oxaliplatin, and adebrelimab) given with radiation therapy before surgery for pancreatic cancer that can be surgically removed or is borderline removable. The goal is to shrink the tumor and improve the chances of successful surgery.
This trial tests whether giving two already-approved chemotherapy drugs and radiation before surgery works better for localized pancreatic cancer. It’s meant for people whose cancer looks removable by surgery and who haven’t had prior pancreatic cancer treatment.
This trial studies giving highly targeted radiation before surgery for patients with operable pancreatic cancer. The goal is to shrink or control the cancer before an operation while keeping side effects manageable.
This trial compares adding radiation to chemotherapy versus chemotherapy alone after surgery for pancreatic cancer. It is for people whose cancer had certain high-risk features found during surgery, and who have not yet started additional treatment.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.